Filter
447
Text search:
registered
pharmaceutical
product
Featured
Recommendations
38
New Publications
135
Language
Document type
No document type
266
Studies & Reports
66
Guidelines
61
Manuals
24
Strategic & Response Plan
13
Training Material
7
Fact sheets
5
Situation Updates
4
Resource Platforms
1
Countries / Regions
Kenya
24
Ethiopia
23
South Africa
19
Uganda
16
India
16
Nigeria
15
Liberia
14
Tanzania
14
Malawi
13
Zimbabwe
12
Sierra Leone
11
Ghana
11
Rwanda
11
Zambia
8
Western and Central Europe
8
Bangladesh
7
Namibia
7
Eswatini/ Swaziland
7
Nepal
6
Botswana
6
Global
6
Philippines
5
Lesotho
5
Cambodia
4
Indonesia
4
Ukraine
4
Myanmar / Burma
4
Senegal
3
Haiti
3
Syria
3
Eastern Europe
3
Albania
3
Sudan
2
Benin
2
North Macedonia
2
Latin America and the Carribbean
2
United Kingdom
2
Burkina Faso
1
Congo, Democratic Republic of
1
Cameroon
1
Pakistan
1
South Sudan
1
Jordan
1
Thailand
1
China
1
Ireland
1
Mozambique
1
Central African Republic
1
Libya
1
Angola
1
South–East Asia Region
1
Asia
1
Africa
1
Venezuela
1
Southern Africa
1
Russia
1
Bulgaria
1
Moldova
1
Iran
1
Australia
1
North America
1
Denmark
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
257
Clinical Guidelines
20
Pharmacy & Technologies
18
Key Resources
13
Public Health
10
Capacity Building
5
Women & Child Health
5
Toolboxes
Pharmacy
64
AMR
42
TB
25
HIV
19
COVID-19
15
Mental Health
14
NTDs
8
Conflict
7
Global Health Education
5
Caregiver
5
Rapid Response
4
Disability
3
Planetary Health
3
Specific Hazards
2
Ebola
1
Cholera
1
Polio
1
Refugee
1
Health Financing Toolbox
1
NCDs
1
Fact Book on WHO Level I and Level II monitoring indicators - To monitor the progress of efforts to improve the global medicines situation, WHO has developed a system of indicators that measure important aspects of a country’s pharmaceutical situa
...
This guideline is intended to provide requirements to applicants wishing to submit
applications for registration of medicines in Botswana.
This guidance should be followed if an unlicensed medicine is prepared in
a registered pharmacy. The preparation of an unlicensed medicine (for
example unlicensed methadone, or menthol in aqueous cream) in a pharmacy is called ‘extemporaneous
...
Irresponsible pharmaceutical companies fuel the proliferation of superbugs through supply chain pollution, the European Public Health Alliance (EPHA) reports. The advocacy group uncovered lapses such as dirty production and inadequate waste disposal
...
This Pharmaceutical Country Profile for Kenya (2010) has been developed by the Ministry of Medical Services with support of the World Health Organization. The Profile contains information on existing socio-economic and health-related conditions, res
...
This guideline is intended to provide recommendations to applicants wishing to submit applications for the registration of medicines. It represents the Medicines Control Council’s current thinking on the safety, quality and efficacy of medicines.
Guidelines for the production of extemporaenous formulations and hospital based sterile preparations
In order to streamline and effectively control compounding of medicinal products in hospitals and pharmacies, these Guidelines for Production of Extemporaneous and Hospital Based Sterile Preparations has been crafted. The purpose of these guidelines therefore is to assist pharmacists in
...
First edition, November 1997 | Revised July 2002
Globally each year, millions of people suffer illness or lose their lives because the vaccines, medicines and diagnostic tests that they need are either unavailable or unaffordable – and this lack of access to medicine is acute in low- and middle-in-
come countries (LMICs). While the COVID-19 pan
...
